It’s time to put COVID boosters and influenza vaccines on your radar
COVID boosters are available at pharmacies for persons age 12 and up who have completed a primary series or been boosted at least two months ago. The vaccine is bivalent, containing spike proteins from Omicron subvariants BA4/5 as well as the original strain. Stay tuned for more information on availability of COVID boosters at MFA.
Influenza has been smoldering at low levels throughout the summer, but has generally taken a break from its seasonal pattern for the past couple of years. We can probably expect a substantial spike of influenza cases this fall/winter and need to be prepared by having patients and healthcare personnel (and our families) immunized early on. This is not the year to wait on influenza vaccination.
Please see yesterday’s “Fight the Flu!” email regarding how to obtain influenza vaccine for patients, and where staff can seek influenza immunization.
Please give Evusheld for pre-exposure prophylaxis to your immunosuppressed patients
We encourage use of Evusheld (tixagevimab plus cilgavimab) for eligible patients. Remember that patients who received Evusheld more than 6 months ago and remain eligible should get another dose.
Evusheld is not authorized for the treatment of COVID-19, as post-exposure prophylaxis, or as a substitute for vaccination among vaccine-hesitant patients.
For administration in MFA, please see these prescribing and administration checklists for MFA providers and MFA staff.
If you have questions, please contact Jose Lucar, MD ([email protected]), or Tara Palmore, MD ([email protected]), for clinical practice; or Ryan Mouton, PharmD ([email protected]) for the MFA Clinic Dispensary.
|